SCHEMBL422099

SCHEMBL422099

FC(F)(F)Cn1ccnc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP11B1 P15538 5/20 0.50
CYP11B2 P19099 4/20 0.50
FDPS P14324 2/20 0.50
GGPS1 O95749 3/20 0.48
BTN3A1 O00481 1/20 0.48
CA12 O43570 1/20 0.48
CA2 P00918 1/20 0.48
LMNA P02545 1/20 0.48
MMP2 P08253 1/20 0.48
MMP9 P14780 1/20 0.48
MMP8 P22894 1/20 0.48
MMP14 P50281 1/20 0.48
CA9 Q16790 1/20 0.48
CA14 Q9ULX7 1/20 0.48
TBXAS1 P24557 3/20 0.48
CYP2B6 P20813 1/20 0.44
ALDH1A1 P00352 1/20 0.43
CYP19A1 P11511 2/20 0.42
L3MBTL1 Q9Y468 1/20 0.42
NOS1 P29475 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13105208 0.80 CYP11B1 (0.53) CYP11B1CYP11B2FDPSGGPS1BTN3A1
SCHEMBL9783083 0.79 CYP11B1 (0.53) CYP11B1CYP11B2TBXAS1CYP19A1CYP1A2
SCHEMBL7295079 0.79 CYP11B1 (0.44) CYP11B1CYP11B2FDPSGGPS1BTN3A1
SCHEMBL20798128 0.79 CYP11B1 (0.44) CYP11B1CYP11B2FDPSGGPS1BTN3A1
SCHEMBL29152236 0.76 CYP11B1 (0.50) CYP11B1CYP11B2FDPSGGPS1BTN3A1
SCHEMBL2697302 0.76 CYP11B1 (0.50) CYP11B1CYP11B2FDPSGGPS1BTN3A1
SCHEMBL26803165 0.76 FDPS (0.42) CYP11B1CYP11B2FDPSGGPS1BTN3A1
SCHEMBL19792816 0.74 FDPS (0.67) CYP11B1CYP11B2FDPSGGPS1BTN3A1
SCHEMBL26793522 0.74 FDPS (0.41) CYP11B1CYP11B2FDPSGGPS1BTN3A1
SCHEMBL28639444 0.73 FDPS (0.52) CYP11B1CYP11B2FDPSGGPS1BTN3A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 45 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109153651-A amido-substituted cyclohexane derivatives 拜耳制药股份公司 2019-01-04 CN claimed
CN-119447517-A Method for repairing capacity of waste lithium ion battery 陕西奥林波斯电力能源有限责任公司 2025-02-14 CN disclosed
CN-117924183-A Lithium ion battery electrolyte additive, preparation method and application thereof 国科温州研究院(温州生物材料与工程研究所) 2024-04-26 CN disclosed
CN-116583521-A Imidazopyridazine derivatives as IL-17 modulators UCB生物制药有限责任公司 2023-08-11 CN disclosed
EP-3883037-B1 ELECTROLYTE FOR LITHIUM SECONDARY BATTERY AND LITHIUM SECONDARY BATTERY INCLUDING THE SAME LG ENERGY SOLUTION LTD (KR) 2023-03-01 EP disclosed
CN-111974166-A Regenerable solvent mixtures for acid gas separation 三角形研究学会 2020-11-24 CN disclosed
CN-104271219-B Regenerable solvent mixtures for acid gas separation 三角形研究学会 2020-08-21 CN disclosed
CN-105793256-B Imdazole derivatives 豪夫迈·罗氏有限公司 2019-09-10 CN disclosed
US-10174003-B2 Histone demethylase inhibitors CELGENE QUANTICEL RESEARCH, INC. (US) 2019-01-08 US disclosed
CN-109153651-A amido-substituted cyclohexane derivatives 拜耳制药股份公司 2019-01-04 CN disclosed
US-7534509-B2 Ambient-temperature molten salts and process for producing the same TOYOTA JIDOSHA KABUSHIKI KAISHA (JP) 2009-05-19 US disclosed
US-20090105400-A1 Imidazolium side chains for example; for example polymers based on 1-methyl-3-(2H,9H,9H-perfluoro-3,6-dioxa-5-methyl-8-nonenyl)-imidazolium trifluoromethanesulfonate; polymer electrolytes for fuel cell, secondary battery, capacitor, dye-sensitized solar cell and electrochromic device DAIKIN INDUSTRIES, LTD. (JP) 2009-04-23 US disclosed
EP-1983008-A1 FLUORINE-CONTAINING POLYMER CONTAINING HETEROAROMATIC RING Daikin Industries, Ltd. (JP) 2008-10-22 EP disclosed
EP-1981034-A1 ACTUATOR ELEMENT Daikin Industries, Ltd. (JP) 2008-10-15 EP disclosed
US-20070225503-A1 Ambient-temperature molten salts and process for producing the same TOYOTA JIDOSHA KABUSHIKI KAISHA 2007-09-27 US disclosed
US-20070225503-A1 Ambient-temperature molten salts and process for producing the same TOYOTA JIDOSHA KABUSHIKI KAISHA 2007-09-27 US disclosed
US-20070203345-A1 Ambient-temperature molten salts and process for producing the same TOYOTA JIDOSHA KABUSHIKI KAISHA 2007-08-30 US disclosed
US-20070203345-A1 Ambient-temperature molten salts and process for producing the same TOYOTA JIDOSHA KABUSHIKI KAISHA 2007-08-30 US disclosed
CN-1093535-C Imidazole derivative SHIONOGI & CO (JP) 2002-10-30 CN disclosed
CN-1158609-A Imidazole derivative SHIONOGI & CO (JP) 1997-09-03 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070203345-A1 Ambient-temperature molten salts and process for producing the same AFF1, AFF2, AFF4 CYP11B1 213/4885CYP11B2 361/4885FDPS 605/4885
US-10174003-B2 Histone demethylase inhibitors KDM1B, KDM1A, KDM3B CYP11B1 2596/4885CYP11B2 3304/4885FDPS 3490/4885
US-20070225503-A1 Ambient-temperature molten salts and process for producing the same AFF1, AFF2, AFF4 CYP11B1 213/4885CYP11B2 361/4885FDPS 605/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.